Alivira Animal Health Profile
Key Indicators
- Authorised Capital ₹ 158.00 Cr
- Paid Up Capital ₹ 47.78 Cr
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 850.50 Cr
- Satisfied Charges ₹ 734.40 Cr
- Revenue Growth 13.69%
- Profit Growth -53.21%
- Ebitda -27.28%
- Net Worth 5.57%
- Total Assets 10.26%
About Alivira Animal Health
Alivira Animal Health Limited (AAHL) is a leading Public Limited Indian Non-Government Company incorporated in India on 30 September 2013 and has a history of 11 years and four months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 158.00 Cr and a paid-up capital of Rs 47.78 Cr.
The company currently has active open charges totaling ₹850.50 Cr. The company has closed loans amounting to ₹734.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Alivira Animal Health Limited India are Saurav Bhala as CFO and Nihar Das as Company Secretary. Kamal Sharma, Sharat Narasapur, Rajaram Narayanan, and Two other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74120MH2013PLC248708
- Company No.
248708
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2013
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Alivira Animal Health Limited offer?
Alivira Animal Health Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Medicines, Animal Treatment Services.
Who are the key members and board of directors at Alivira Animal Health?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajaram Narayanan  | Managing Director | 11-Apr-2022 | Current |
| Saurav Bhala | CFO | 16-Nov-2023 | Current |
| Nihar Das | Company Secretary | 25-Jun-2022 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Sharma | Director | 09-Sep-2020 | Current |
| Sharat Narasapur | Director | 08-Jan-2017 | Current |
| Vijayalakshmi | Director | 15-Dec-2021 | Current |
| Vedprakash Ragate | Director | 06-Apr-2024 | Current |
Financial Performance of Alivira Animal Health.
Alivira Animal Health Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.69% increase. The company also saw a substantial fall in profitability, with a 53.21% decrease in profit. The company's net worth moved up by a moderate rise of 5.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alivira Animal Health?
In 2021, Alivira Animal Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Symed Labs LimitedKamal Sharma and Vijayalakshmi are mutual person
Shilpa Medicare LimitedKamal Sharma is a mutual person
Sequent Scientific LimitedKamal Sharma, Rajaram Narayanan and 2 more are mutual person
- Sequent Research Limited
Rajaram Narayanan and Vedprakash Ragate are mutual person
Viyash Life Sciences Private LimitedKamal Sharma is a mutual person
Templecraft Realty LlpKamal Sharma is a mutual person
Charges (Loans)
₹850.50 Cr
₹734.40 Cr
Charges Breakdown by Lending Institutions
- Others : 750.00 Cr
- Hdfc Bank Limited : 55.00 Cr
- Citi Bank N.A. : 30.50 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2024 | Others | ₹360.00 Cr | Open |
| 16 Apr 2024 | Others | ₹360.00 Cr | Open |
| 27 Jul 2021 | The Hongkong And Shanghai Banking Corporation Limited | ₹15.00 Cr | Open |
| 14 Aug 2020 | Citi Bank N.A. | ₹30.50 Cr | Open |
| 27 Sep 2019 | Others | ₹30.00 Cr | Open |
How Many Employees Work at Alivira Animal Health?
Alivira Animal Health has a workforce of 850 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alivira Animal Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alivira Animal Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
